Accelerating the transition of new tuberculosis drug combinations from Phase II to Phase III trials: New technologies and innovative designs

Geraint Davies and colleagues discuss the potential for innovative early-phase clinical trial methods and technologies to reduce risk and speed up drug development for tuberculosis.

Detalles Bibliográficos
Autores principales: Davies, Geraint, Boeree, Martin, Hermann, Dave, Hoelscher, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Collection Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6615592/
https://www.ncbi.nlm.nih.gov/pubmed/31287813
http://dx.doi.org/10.1371/journal.pmed.1002851

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6615592/
https://www.ncbi.nlm.nih.gov/pubmed/31287813
http://dx.doi.org/10.1371/journal.pmed.1002851

Ejemplares similares